Conceptual Development of Industrial Biotechnology for Commercial Production of Vaccines and Biopharmaceuticals (Developments in Applied Microbiology and Biotechnology) - Softcover

Behera

 
9780443187483: Conceptual Development of Industrial Biotechnology for Commercial Production of Vaccines and Biopharmaceuticals (Developments in Applied Microbiology and Biotechnology)

Inhaltsangabe

Conceptual Development of Industrial Biotechnology for Commercial Production of Biopharmaceuticals and Vaccines provides insights on how to bring sustainability into biologic drug production. The cumulative facts and figures within in the book are helpful to promoters in monitoring value chain transfer process of super quality biologics for better return in profits. In addition, this is a useful reference for students, researchers and scientists in biotechnology, pharmaceutical science, medical sciences, and the R&D division of biotechnology-based industries. Conceptual development of biotechnology has taken new avenues with the integration of medical sciences, physical science, and engineering, hence this is a timely source. The current global market for vaccines, especially COVID-19, is tremendous. Bivalent oral polio vaccine, diphtheria, tetanus-containing, and measles-containing vaccines have a high demand internationally and recombinant DNA technology and protein engineering are helpful in the production of quality bio-products.

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Über die Autorin bzw. den Autor

Dr. Basanta Kumara Behera was a Professor of Biotechnology at three distinguished Indian universities, where he taught and conducted research at the post-graduate level on medical biotechnology, biopharmaceutical, microbial process development, drug designing, bio-energy management, and biomass processing technology since 1978. In 2009, he joined an MNC company as an advisor for specialty chemicals production and drug design through microbial process technology. He is associated with national and international companies as a technical advisor to produce biopharmaceuticals under cGMP norms. Dr. Behera has authored and edited books with various publishers worldwide.

Von der hinteren Coverseite

Conceptual development of biotechnology has taken a new shape and style with the integration of medical sciences, physical science, and engineering, in developing microbial or cell line process technology and their application for large-scale isolation and purification of metabolites or vaccines through the fermentation process.These metabolites are in the form of biologic drugs which are widely used in biopharmaceutical, biochemical, food, nutraceuticals, and diagnostics. The current global market for vaccines, especially COVID-19, is tremendous. Bivalent oral polio vaccine, diphtheria, tetanus-containing, and measles-containing vaccines have a high demand internationally and recombinant DNA technology and protein engineering are helpful in the production of quality bio-products. Conceptual Development of Industrial Biotechnology for Commercial Production of Biopharmaceuticals and Vaccines provides insight on how to bring sustainability into biologic drugs production. The cumulative facts and figures within in the book are helpful to promoters in monitoring value chain transfer process of super quality biologics for better return, in terms of profits. In addition, it is a useful reference for the students, researchers, and scientists belonging to biotechnology, pharmaceutical science, medical sciences, and the R&D division of biotechnology-based industries, to understand the latest information on industrial biotechnology and how to apply that learning to be an entrepreneur and develop start-up projects for the commercialization of biologics.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.